Short answer
HAEMONETICS CORP (HAE) filed an 8-K current report with the SEC on October 8, 2026 reporting Item 7.01 (Regulation FD Disclosure). CSL expects rollout of Haemonetics’ NexSys PCS devices and Persona PLUS disposables across all current U.S. plasma centers by end-2027.
HAEMONETICS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- CSL expects rollout of Haemonetics’ NexSys PCS devices and Persona PLUS disposables across all current U.S. plasma centers by end-2027
- Potentially broad customer conversion expands Haemonetics’ recurring disposable-product opportunity with a major plasma collector
- Non-exclusive agreement leaves rollout scope, timing and purchase volumes subject to change
- Fiscal 2027 guidance unchanged, with expected financial impact update planned for the second-quarter earnings call in November 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HAEMONETICS CORP 8-K filings
Get the next HAE 8-K as it lands
Follow HAE for push alerts, or ask the research agent what this filing means.